Harm reduction policies for tobacco users

International Journal of Drug Policy

Volumn 21, Issue 2, 2010, Pages 129-130

  Gartner, Coral ^a   Hall, Wayne ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Pharmaceutical nicotine; Smokeless tobacco; Smoking; Snus; Tobacco harm reduction

Indexed keywords

NICOTINIC AGENT;

ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; COST BENEFIT ANALYSIS; HARM REDUCTION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROMOTION; HUMAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SMOKELESS TOBACCO; SMOKING CESSATION; TOBACCO DEPENDENCE; TOBACCO INDUSTRY;

EID: 77649275478     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2009.10.008     Document Type: Note

References (17)

1. ASPECT Consortium. Tobacco or health in the European Union (2004), European Commission, Luxembourg. http://ec.europa.eu/health/ph_determinants/life_style/Tobacco/Documents/tobacco_fr_en.pdf Retrieved from http://ec.europa.eu/health/ph_determinants/life_style/Tobacco/Documents/tobacco_fr_en.pdf
2. Brandt A.M. The Cigarette Century (2007), Basic Books, New York
3. Broadstock M. Systematic review of the health effects of modified smokeless tobacco products. NZHTA Report 10 1 (2007)
4. Foulds J., Ramström L., Burke M., and Fagerström K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tobacco Control 12 4 (2003) 349-359
5. Gartner C.E., and Hall W.D. The potential role of snus in tobacco harm reduction. Addiction 104 9 (2009) 1586-1587
6. Gartner C.E., Hall W.D., Vos T., Bertram M.Y., Wallace A.L., and Lim S.S. Assessment of Swedish snus for tobacco harm reduction: An epidemiological modelling study. The Lancet 369 9578 (2007) 2010-2014
7. Haddock C.K., Vander Weg M., DeBon M., Klesges R.C., Talcott G.W., Lando H., et al. Evidence that smokeless tobacco use is a gateway for smoking initiation in young adult males. Preventive Medicine 32 3 (2001) 262-267
8. Kozlowski L.T., and O'Connor R.J. Apply federal research rules on deception to misleading health information: An example on smokeless tobacco and cigarettes. Public Health Reports 118 3 (2003) 187-192
9. Kozlowski L.T., Strasser A.A., Giovino G.A., Erickson P.A., and Terza J.V. Applying the risk/use equilibrium: Use medicinal nicotine now for harm reduction. Tobacco Control 10 3 (2001) 201-203
10. O'Connor R.J., Kozlowski L.T., Flaherty B.P., and Edwards B.Q. Most smokeless tobacco use does not cause cigarette smoking: Results from the 2000 National Household Survey on Drug Abuse. Addictive Behaviors 30 2 (2005) 325-336
11. Parascandola M. Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette". Nicotine & Tobacco Research 7 5 (2005) 779-789 10.1080/14622200500262584
12. Pollay R.W., and Dewhirst T. The dark side of marketing seemingly "Light" cigarettes: successful images and failed fact. Tobacco Control 11 Suppl. I (2002) i18-i31
13. Ramström L.M., and Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tobacco Control 15 3 (2006) 210-214
14. Royal College of Physicians. Harm reduction in nicotine addiction: helping people who can't quit. A report by the Tobacco Advisory Group of the Royal College of Physicians (2007), RCP, London
15. Timberlake D.S., Huh J., and Lakon C.M. Use of propensity score matching in evaluating smokeless tobacco as a gateway to smoking. Nicotine & Tobacco Research 11 4 (2009) 455-462
16. Warner K.E., and Martin E.G. The US tobacco control community's view of the future of tobacco harm reduction. Tobacco Control 12 4 (2003) 383-390
17. Warner K.E., Slade J., and Sweanor D.T. The emerging market for long-term nicotine maintenance. JAMA 278 13 (1997) 1087-1092